Sunday 11 October 2026 Export all BAK data to Excel Powerpack

Braskem S.A.

BAK Basic Materials Chemicals

In the quarter to June 2026, revenue fell 100.0%, EPS grew 1,278.6%, free cash flow grew 611.1% and total debt fell 99.9%, each against the same quarter a year earlier.

1.82 0.00 0.00%
Market cap
$314.0M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
0.28
Beneish M
−1.53
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 56.72%

Capital & Financial Ratios $m

Market Cap 314.00
Revenue 9,133.20
Net Income (559.13)
Free Cash Flow (615.55)
Net Debt 11.49
Current Ratio 0.77 (below 1: weak)
Debt/Equity (4.91) (negative: negative equity)
P/E ratio 0.00
Fwd P/E —
P/S ratio 0.08
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 119.31% (at or above 15%: strong)
Next Y EPS Growth (212.64%) (below 0%: weak)
Next Y revenue growth —
Next 5Y EPS Growth 44.99% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 3.73%
10-year low 10-year high
EV/Sales against its own 10 years 0.91%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2022 0.67
0.67
2021 2.63
2.63
2019 0.41
0.41
2017 0.78
0.78
2016 1.49
0.71
0.77
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 3,862 3,123 2,185 1
Receivables 1,127 1,206 1,401 1
Inventory 2,510 2,538 1,866 3
Other — 146 — 1
7,499 6,867 5,453 6
2023 2024 2025 Q'26
Payables 2,648 3,130 2,360 2
ST’ Debt 554 581 3,720 4
Other 821 606 385 0
4,906 5,242 7,203 8

Compound Annual Growth %

10y 5y 3y
Sales (1.30%) 2.20% (12.17%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 2,941 0 — — —
’25 3,322 3,152 3,176 3,016 12,665
’24 3,618 3,655 3,834 3,245 14,352
’23 3,743 3,587 3,415 3,390 14,135
’22 5,116 5,164 4,710 3,590 18,696
’21 4,153 4,988 5,417 5,015 19,572
’20 2,852 2,087 2,976 3,443 11,357
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (807) 806 — — —
’25 (398) (64) (144) (146) (752)
’24 195 267 (170) 160 451
’23 (539) 373 (507) 218 (455)
’22 327 426 545 437 1,734
’21 422 488 1,111 720 2,740
’20 484 (207) 180 764 1,221
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (935) 930 — — —
’25 (510) (182) (386) (235) (1,313)
’24 19 91 (300) (45) (235)
’23 (763) 186 (763) (7) (1,348)
’22 194 192 545 437 795
’21 422 264 951 477 2,113
’20 280 (276) 96 592 692
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.69 1.65 — — —
’25 0.30 (0.14) (0.02) (4.75) (4.44)
’24 (0.68) (1.80) (0.27) (2.42) (5.27)
’23 0.09 (0.42) (1.24) (0.80) (2.30)
’22 1.87 (0.72) (0.26) (0.41) (0.16)
’21 1.15 3.52 1.70 0.24 6.51
’20 (2.07) (1.16) (0.66) 0.68 (3.26)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3.6
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 10.82 17.44 21.32 12.31 3.86 8.53 8.41 6.26 3.70 2.32

Analyst estimates 2026–2028

Powerpack
High 21.43 33.73 32.67 30.38 18.64 26.93 21.22 12.67 10.98 5.10
People
People Employees 7,657 7,713 8,008 7,940 7,993 8,312 8,668 366 8,382 8,233
Revenue/emp, $m 1.78 2.00 1.98 1.67 1.42 2.35 2.16 38.62 1.71 1.54
Income, $m
Income, $m Revenue 13,665 15,428 15,869 13,259 11,357 19,572 18,696 14,135 14,352 12,665
Gross margin, % 26.69 26.56 19.95 12.32 19.15 30.35 11.77 4.28 7.75 2.20
EBT (40) 1,649 986 (1,166) (1,879) 3,328 9 (1,240) (3,288) (510)
EBT margin, % (0.29) 10.69 6.22 (8.80) (16.54) 17.00 0.05 (8.77) (22.91) (4.02)
Net income (28) 1,649 986 (1,166) (1,879) 3,328 9 (1,240) (3,288) (510)
Depreciation 769 917 818 920 785 774 917 1,043 918 837
Per share, $
Per share, $ Revenue 60.51 38.76 39.87 33.31 28.54 49.16 46.95 35.47 36.01 31.77
Earnings (0.32) 3.21 1.97 (1.71) (3.26) 6.51 (0.16) (2.30) (5.27) (4.44)
Cash flow 6.03 1.94 6.36 1.44 3.07 6.88 4.35 (1.14) 1.13 (1.89)
Capex (3.65) (1.76) (1.80) (1.70) (1.33) (1.57) (2.36) (2.24) (1.72) (1.41)
Free cash flow 2.38 0.18 4.56 (0.26) 1.74 5.31 2.00 (3.38) (0.59) (3.29)
Book value 2.18 4.31 3.89 2.51 (1.88) 2.89 2.97 1.65 (1.99) (7.41)
Shares, m 226 398 398 398 398 398 398 398 399 399
Valuation, ×
Valuation, × P/E 0.00 8.30 11.87 0.00 0.00 3.25 17.00 0.00 0.00 0.00
P/S 0.36 0.70 0.61 0.44 0.32 0.43 0.08 0.24 0.11 0.09
P/B 10.10 6.33 6.29 5.89 0.00 7.30 1.03 5.21 0.00 0.00
EV/Sales 0.72 1.29 1.13 1.08 0.99 0.80 0.47 0.76 0.79 0.87
EV/FCF 18.40 321.54 9.79 (162.69) 15.98 7.97 9.00 (8.08) (51.11) (8.50)
Cash, $m
Cash, $m Operating cash flow 1,361 771 2,531 574 1,221 2,740 1,734 (455) 451 (752)
Capex (824) (700) (714) (677) (529) (626) (939) (893) (687) (561)
Free cash flow 537 71 1,816 (103) 692 2,113 795 (1,348) (235) (1,313)
Balance, $m
Balance, $m Working capital (1,944) (359) (474) 1,818 1,126 2,613 1,990 2,593 1,625 (1,750)
Total debt 7,154 11,000 10,364 10,559 11,106 9,460 9,605 11,212 12,870 12,029
Net debt 4,888 9,096 8,194 8,406 7,707 7,198 6,715 7,350 9,747 9,844
Shareholders’ equity 493 1,714 1,547 1,000 (750) 1,150 1,183 657 (793) (2,956)
Returns, %
Returns, % ROA (0.71) 7.72 4.75 (3.86) (7.64) 15.31 (0.38) (5.18) (11.28) (10.57)
ROIC 19.81 16.67 14.54 0.26 (0.13) 36.13 6.55 (4.37) (1.40) (2.94)
ROE (26.17) 109.69 47.45 (50.57) (1,040.70) 1,297.44 (5.57) (99.70) 3,078.28 94.41
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Braskem S.A. vs peers in Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
WLKP Westlake Chemical Partners LP $754.6M 13.0× 12.3× −0.01% (below 0%: shrinking) −2.44% (below 0%: shrinking) +866.65% (above 0%: growing) 31.91% 29.39% Compare
LXU Lsb Industries Inc. $729.3M 19.6× 12.8× +11.10% (above 0%: growing) n/m +9,653.02% (above 0%: growing) 6.82% (1.63%) Compare
TROX Tronox Holdings PLC $603.7M — (loss-making) — (loss-making) +18.74% (above 0%: growing) n/m +241.51% (above 0%: growing) 6.34% (2.42%) Compare
RYAM Rayonier Advanced Materials Inc. $468.8M — (loss-making) — (loss-making) +10.61% (above 0%: growing) n/m +69.92% (above 0%: growing) 6.10% (1.69%) Compare
ASIX AdvanSix $450.9M — (loss-making) 24.1× +2.75% (above 0%: growing) −89.74% (below 0%: shrinking) −49.21% (below 0%: shrinking) 7.38% 2.15% Compare
ASPI ASP Isotopes Inc. $433.9M — (loss-making) — (loss-making) +327.63% (above 0%: growing) n/m −182.92% (below 0%: shrinking) 28.89% (667.48%) Compare
VHI Valhi, Inc. $422.3M — (loss-making) 7.0× +9.82% (above 0%: growing) +2,500.00% (above 0%: growing) +435.16% (above 0%: growing) 22.56% 9.88% Compare
BAK Braskem S.A. $314.0M — (loss-making) — −99.99% (below 0%: shrinking) n/m +611.13% (above 0%: growing) 80.35% 48.61%
ACNT Ascent Industries Co. $123.3M — (loss-making) — (loss-making) +37.61% (above 0%: growing) −89.23% (below 0%: shrinking) −97.54% (below 0%: shrinking) 21.62% (1.02%) Compare
Median of peers $459.8M — 12.6× +10.86% −45.83% +155.72% 14.50% (1.32%)

All 17 Chemicals stocks →

Braskem S.A. (BAK) key facts

  • Braskem S.A. (BAK) is a Chemicals company in the Basic Materials sector, traded in the US as an ADR.
  • As of October 9, 2026, BAK traded at $1.82, a market capitalization of $314.0 million.
  • Return on equity was 94.4% and debt-to-equity -4.91.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 0.28 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Braskem S.A. (BAK) Latest News

14 Aug

Impact 3 · transcript

14 May

27 Mar

28 Feb

stockrow.com/BAK · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com